|Articles|August 1, 2000

August 2000
Volume 6
Issue 8

Proton Pump Inhibitors: Cost-Effective Agents for Management of Reflux-Induced Esophagitis

Author(s)James C. Gregor, MD, FRCPC

Download PDF: Proton Pump Inhibitors: Cost-Effective Agents for Management of Reflux-Induced Esophagitis

Articles in this issue

almost 26 years ago

Article

What Price an Additional Day of Life? A Cost-Effectiveness Study of Case Management

almost 26 years ago

Article

Use of Randomized Controlled Trials in Organizational Decision Making: A Cost-Minimization Approach

almost 26 years ago

Article

Cost Effectiveness of Rabeprazole Versus Generic Ranitidine for Symptom Resolution in Patients with Erosive Esophagitis

almost 26 years ago

Article

Medicare Disenrollment and Selective Use of Medical Care: Osteoarthritis-Related Joint Replacement

almost 26 years ago

Article

The Community Assessment Risk Screen (CARS): Identifying Elderly Persons at Risk for Hospitalization or Emergency Department Visit

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Proton Pump Inhibitors: Cost-Effective Agents for Management of Reflux-Induced Esophagitis

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Study Finds Flaw in Method for Key Oncology Value-Based Care Model

Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer